Skip to content
Screener

ADMA Biologics ADMA ADMA Bio Manufacturing — General And Administrative Expense

Other segment segments

Plasma Collection Centers
$0

Similar metrics at other companies

Consolidated Water Company logo
CWCOManufacturing Units — General And Administrative Expense
$519.07K-2.2%
Beam Therapeutics logo
BEAMExternal General And Administrative Expenses — General And Administrative Expense
$13.37M+149%
Solid Biosciences Inc. logo
SLDBExternal General And Administrative Expense — General And Administrative Expense
$6.33M+19.9%
Solid Biosciences Inc. logo
SLDBInternal General And Administrative Expense — General And Administrative Expense
$4.73M+40.9%
TRA
TRAXExternal Expenses — General And Administrative Expense
$8.72M+127%
AnaptysBio, Inc. logo
ANABExternal Expenses — General And Administrative Expense
$12.12M+119%

Other financials

Income statement

See full
Revenue$124.4M+2.0%
Gross profit$86.3M+28.3%
Operating income$52.4M+22.5%
Net income$37.8M+10.5%
EPS (diluted)$0.16+14.3%

Balance sheet

See full
Cash & equivalents$136.0M+50.7%
Total debt$203.9M+1,855%
Total equity$408.2M+2.5%
Total assets$684.2M+22.5%

Cash flow

See full
Operating cash flow$29.5M+39.7%
CapEx$2.3M-6.9%
Free cash flow$27.3M+45.8%

Valuation

See full
Market cap$2.22B-44.1%
Enterprise value$2.29B-41.2%
P/E13.1×-5.9×
P/S4.3×-4.0×

Profitability

See full
Gross margin64.7%+11.7pp
Operating margin43.8%+11.0pp
Net margin33%-11.1pp
FCF margin22.7%+8.9pp

Returns & leverage

See full
Return on equity41.9%-29.3pp
Debt / equity0.5×+0.5×
Current ratio+1.6×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:16 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001140361-26-031445
(in thousands)ADMA Bio ManufacturingPlasma Collection CentersTotal
Gain on sale of plasma centers---
Selling, marketing and distribution7,634-7,634
Depreciation and amortization expense1,2814991,780
General and administrative expense8,340-8,340
Other income (expense), net(20)150130
Income (loss) before taxes64,010(707)63,303
Expenditures for additions to long-lived assets2,256-2,256
Total assets453,53821,864475,402

Item 1. Financial Statements.

FAQ

What is ADMA Biologics's ADMA bio manufacturing — general and administrative expense?
ADMA Biologics (ADMA) reported ADMA bio manufacturing — general and administrative expense of $8.34M in Q2 2026.
How has ADMA Biologics's ADMA bio manufacturing — general and administrative expense changed year-over-year?
ADMA Biologics's ADMA bio manufacturing — general and administrative expense decreased by 44.2% year-over-year, from $14.94M to $8.34M.
What is the long-term trend for ADMA Biologics's ADMA bio manufacturing — general and administrative expense?
Over 2 years (2022 to 2024), ADMA Biologics's ADMA bio manufacturing — general and administrative expense has grown at a 18.4% compound annual growth rate (CAGR), from $16.31M to $22.86M.
What does ADMA bio manufacturing — general and administrative expense mean?
Includes overhead costs such as executive salaries, legal, accounting, and other corporate support functions allocated to the manufacturing segment. This metric is used to evaluate the operational leverage and cost discipline of the business unit.

Ask your AI about ADMA Biologics's adma bio manufacturing — general and administrative expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude